[XEN ® Gel Stent for management of chronic open angle glaucoma: A review of the literature (French translation of the article)].

CONCLUSION: XEN® Gel Stent appears effective for reducing IOP and the number of medications in OAG patients within 1 year postoperatively with an acceptable safety profile. However, vigilant postoperative follow-up and frequent postoperative maneuvers are required. PMID: 30879831 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30879831?dopt=Abstract

Source: Journal Francais d Ophtalmologie - March 20, 2019 Category: Opthalmology Tags: J Fr Ophtalmol Source Type: research